Publication

Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study

Downloadable Content

Persistent URL
Last modified
  • 03/03/2025
Type of Material
Authors
    Neda Amini, The Johns Hopkins HospitalYuhree Kim, The Johns Hopkins HospitalAna Wilson, The Johns Hopkins HospitalGeorgios Antonios Margonis, The Johns Hopkins HospitalCecilia G. Ethun, Emory UniversityGeorge Poultsides, Stanford UniversityThuy Tran, Stanford UniversityKamran Idrees, Vanderbilt UniversityChelsea A. Isom, Vanderbilt UniversityRyan C.RC Fields, Washington UniversityBradley Krasnick, Washington UniversitySharon M Weber, University of WisconsinAhmed Salem, University of WisconsinRobert C. G. Martin, University of LouisvilleCharles Scoggins, University of LouisvillePerry Shen, Wake Forest UniversityHarveshp D. Mogal, Wake Forest UniversityCarl Schmidt, Ohio State UniversityEliza Beal, Ohio State UniversityIoannis Hatzaras, New York UniversityRivfka Shenoy, New York UniversityShishir Maithel, Emory UniversityTimothy M. Pawlik, The Johns Hopkins Hospital
Language
  • English
Date
  • 2016-09-01
Publisher
  • Springer Verlag (Germany)
Publication Version
Copyright Statement
  • © 2016, Society of Surgical Oncology.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1068-9265
Volume
  • 23
Issue
  • 9
Start Page
  • 3016
End Page
  • 3023
Supplemental Material (URL)
Abstract
  • Background: Although the American Joint Committee on Cancer (AJCC) classification is the most accepted lymph node (LN) staging system for gallbladder adenocarcinoma (GBA), other LN prognostic schemes have been proposed. This study sought to define the performance of the AJCC LN staging system relative to the number of metastatic LNs (NMLN), the log odds of metastatic LN (LODDS), and the LN ratio (LNR). Methods: Patients who underwent curative-intent resection for GBA between 2000 and 2015 were identified from a multi-institutional database. The prognostic performance of various LN staging systems was compared by Harrell’s C and the Akaike information criterion (AIC). Results: Altogether, 214 patients with a median age of 66.7 years (interquartile range [IQR] 56.5–73.1) were identified. A total of 1334 LNs were retrieved, with a median of 4 (IQR 2–8) LNs per patient. Patients with LN metastasis had an increased risk of death (hazard ratio [HR] 1.87; 95 % confidence interval [CI] 1.24–2.82; P = 0.003) and recurrence (HR 2.28; 95 % CI 1.37–3.80; P = 0.002). In the entire cohort, LNR, analyzed as either a continuous scale (C-index, 0.603; AIC, 803.5) or a discrete scale (C-index, 0.609; AIC, 802.2), provided better prognostic discrimination. Among the patients with four or more LNs examined, LODDS (C-index, 0.621; AIC, 363.8) had the best performance versus LNR (C-index, 0.615; AIC, 368.7), AJCC LN staging system (C-index, 0.601; AIC, 373.4), and NMLN (C-index, 0.613; AIC, 369.5). Conclusions: Both LODDS and LNR performed better than the AJCC LN staging system. Among the patients who had four or more LNs examined, LODDS performed better than LNR. Both LODDS and LNR should be incorporated into the AJCC LN staging system for GBA.
Author Notes
Keywords
Research Categories
  • Health Sciences, Public Health
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items